1. Outcomes of adults with relapsed or refractory Burkitt and high‐grade B‐cell leukemia/lymphoma
- Author
-
Short, Nicholas J, Kantarjian, Hagop M, Ko, Heidi, Khoury, Joseph D, Ravandi, Farhad, Thomas, Deborah A, Garcia‐Manero, Guillermo, Khouri, Maria, Cortes, Jorge E, Wierda, William G, Verstovsek, Srdan, Estrov, Zeev, Ferrajoli, Alessandra, Thompson, Philip A, Pierce, Sherry, O'Brien, Susan M, and Jabbour, Elias
- Subjects
Biomedical and Clinical Sciences ,Cardiovascular Medicine and Haematology ,Adult ,Antineoplastic Agents ,Immunological ,Antineoplastic Combined Chemotherapy Protocols ,Asparaginase ,Burkitt Lymphoma ,Cyclophosphamide ,Dexamethasone ,Disease-Free Survival ,Doxorubicin ,Drug Resistance ,Neoplasm ,Etoposide ,Follow-Up Studies ,Humans ,Kaplan-Meier Estimate ,Leukemia ,B-Cell ,Lymphoma ,B-Cell ,Lymphoma ,Non-Hodgkin ,Methotrexate ,Polyethylene Glycols ,Prednisone ,Recurrence ,Remission Induction ,Retrospective Studies ,Rituximab ,Salvage Therapy ,Treatment Outcome ,Vincristine ,Cardiorespiratory Medicine and Haematology ,Immunology ,Cardiovascular medicine and haematology - Published
- 2017